Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia. (NCT06123650) | Clinical Trial Compass
RecruitingNot Applicable
Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia.
Egypt70 participantsStarted 2025-03-22
Plain-language summary
BACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia. Pneumonia accounts for at least 10% of post stroke deaths within 30 days of hospitalization after stroke. rTMS is effective in improving post-stroke dysphagia and swallowing coordination after stimulation of the unaffected hemisphere, however it's efficacy on the prevalence of pneumonia has not yet been examined.
Purpose of the study: To determine the effect of adding low frequency repetitive transcranial magnetic stimulation to conventional oropharyngeal physical therapy program on the prevalence of aspiration pneumonia in in patients with post stroke dysphagia.
Who can participate
Age range49 Years â 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
â. All the patients were diagnosed of stroke oropharyngeal dysphagia by a neurologist. Sever to moderate dysphagia (GUSS 0-14).
â. Severity of stroke ranged from mild to moderate according to NIHSS score (NIHSS less than or equal 16).
â. Patients' age ranged from 49 to 65 years old.
â. Patients had the ability to understand and follow instructions.
â. Patients were able to sit in upright position.
Exclusion criteria
â. History of previous stroke.
â. History of any swallowing problem.
â. History of any head and neck surgery or tumor that causes swallowing dysfunction.
â. Any lung disease or pneumonia on admission.
â. Patients with cognitive deficits or disturbed conscious level.
What they're measuring
1
The Gugging swallowing screen (GUSS)
Timeframe: Baseline and immediately after the intervention.
2
(A2DS2) scale to detect risk of pneumonia
Timeframe: Baseline and immediately after the intervention.
3
Microbiological Examination of the sputum
Timeframe: Baseline and immediately after the intervention